Table 2.
Initial Clinical Liver Disease Progression Event (n = 55)
| Outcome | HIV/HCV Coinfected N = 421 |
HCV Monoinfected N = 143 |
Total Number N = 564 |
|---|---|---|---|
| Liver related deatha | 24 | 5 | 29 |
| Progressive liver failure | 14 | 2 | 16 |
| Ascites | 3 | 1 | 4 |
| Spontaneous bacterial peritonitis | 2 | 0 | 2 |
| Encephalopathy | 3 | 1 | 4 |
| Variceal bleed | 3 | 2 | 5 |
| Hepatoma | 1 | 1 | 2 |
| Liver disease was a major contributing factor | 5 | 1 | 6 |
| Clinical progression of liver diseasea | 20 | 6 | 26 |
| New ascites | 9 | 3 | 12 |
| New spontaneous bacterial peritonitis | 2 | 0 | 2 |
| New encephalopathy | 7 | 2 | 9 |
| New variceal bleed | 1 | 1 | 2 |
| Hepatoma | 3 | 1 | 4 |
Abbreviations: HCV, hepatitis C virus; HIV, human immunodeficiency virus.
a Subgroups add up to more than total because some individuals were diagnosed with multiple conditions during a single time period.